Tradestie Institutional Equity Comparison Engine

AHCO vs IRMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IRMD Overall Edge

IRMD Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to iRadimed Corporation (IRMD) driven by superior Growth & Margin, Momentum & Technical while AHCO counters with relative strength in Valuation, Options & Structure. Fundamentally, AHCO trades at 7.8x Forward P/E with 3.8% operating margin (+10.9% YoY revenue) versus IRMD at 33.2x Forward P/E and 32.3% operating margin (+14.2% YoY). In options structure, AHCO sits in SURGE (12th %ile IV; Dealer Gamma Walls on Pro) against IRMD sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AHCO
AHCO 7.8x vs IRMD 33.2x Fwd P/E
Growth & Margin Winner IRMD
Op Margin 3.8% vs 32.3% ยท YoY +10.9% vs +14.2%
Momentum & Technical Winner IRMD
1Y -20.9% vs -6.4% ยท 52W Pos 24% vs 15%
Options & Structure Winner AHCO
SURGE (12th %ile IV) vs CONSOLIDATION (6th %ile IV)
AHCO NASDAQ
AdaptHealth Corp. Common Stock
Services-Home Health Care Services
$7.20
-0.69% 1D
Market Cap $989.8M
1M Return +16.69%
1Y Return -20.88%
Forward P/E 7.8x
Unified AI Score
45.2 / 100 HOLD
Tech 29.0 Fund 46.0 Flow 54.0 Mom 60.0
IRMD NASDAQ
iRadimed Corporation
Surgical & Medical Instruments & Apparatus
$81.02
-0.3% 1D
Market Cap $1.0B
1M Return -7.55%
1Y Return -6.43%
Forward P/E 33.2x
Unified AI Score
42.0 / 100 HOLD
Tech 31.0 Fund 48.0 Flow 67.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AHCO -20.88% IRMD -6.43% Spread: +14.45 pp (IRMD Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AHCO Revenue IRMD Revenue AHCO Op. Margin IRMD Op. Margin Margin Edge
FY2018 $350M $30M 9.0% 19.7% IRMD
FY2019 $530M $40M 5.5% 22.5% IRMD
FY2020 $1.06B $30M 6.8% -2.4% AHCO
FY2021 $2.45B $40M 9.2% 23.5% IRMD
FY2022 $2.97B $50M 6.4% 29.3% IRMD
FY2023 $3.20B $70M -18.7% 30.6% IRMD
FY2024 $3.26B $70M 8.1% 30.0% IRMD
FY2025 $3.24B $80M 2.8% 31.2% IRMD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AHCO (4) vs IRMD (6)
Institutional Metric AHCO IRMD Criterion Row Winner
Market Capitalization Scale $989.8M $1.0B Larger Scale IRMD
Trailing P/E Ratio Valuation 7.8x 43.5x Lower Multiple AHCO
Forward P/E Ratio Valuation 7.8x 33.2x Lower Multiple AHCO
Revenue Growth (YoY) Growth +10.9% +14.2% Higher Growth IRMD
Operating Margin (TTM) Profitability 3.8% 32.3% Higher Margin IRMD
Net Profit Margin Profitability -11.8% 26.9% Higher Margin IRMD
Return on Equity (ROE) Capital Efficiency -28.4% 23.4% Higher ROE IRMD
52-Week Range Position Momentum 24% ($5โ€“$13) 15% ($76โ€“$108) Stronger Trend AHCO
Beta / 30D Volatility Risk Regime 0.17ฮฒ ยท 67% Vol 0.67ฮฒ ยท 54% Vol Lower Realized Risk IRMD
Unified Institutional Score Composite Signal 45.2 / 100 (HOLD) 42.0 / 100 (HOLD) Higher Composite AHCO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AHCO vs IRMD Buy Guide
AHCO SURGE
6d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live AHCO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IRMD CONSOLIDATION
98d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live IRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AHCO nor IRMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.